NASDAQ:ESGREnstar Group Stock Price, Forecast & News

Enstar Group's stock was trading at $162.70 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ESGR shares have decreased by 4.1% and is now trading at $155.99. View which stocks have been most impacted by Coronavirus.

Enstar Group is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Enstar Group.

Enstar Group Ltd. (NASDAQ:ESGR) announced its earnings results on Thursday, May, 7th. The insurance provider reported ($15.60) EPS for the quarter. The insurance provider had revenue of $365.71 million for the quarter. Enstar Group had a net margin of 36.46% and a return on equity of 0.96%. View Enstar Group's earnings history.

Media coverage about ESGR stock has been trending somewhat negative recently, according to InfoTrie. The research firm rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Enstar Group earned a daily sentiment score of -1.8 on InfoTrie's scale. They also gave media headlines about the insurance provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about Enstar Group.

Enstar Group saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 147,600 shares, an increase of 5.4% from the June 15th total of 140,000 shares. Based on an average daily volume of 57,500 shares, the days-to-cover ratio is currently 2.6 days. Approximately 1.0% of the company's stock are short sold. View Enstar Group's Current Options Chain.

Some companies that are related to Enstar Group include Everest Re Group (RE), RenaissanceRe (RNR), Alleghany (Y), Reinsurance Group of America (RGA), Greenlight Capital Re (GLRE), Maiden (MHLD) and Partnerre (PRE.PH). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Enstar Group investors own include Exxon Mobil (XOM), Gilead Sciences (GILD), Ring Energy (REI), Ring Energy (REI), AbbVie (ABBV), Blackstone Group (BX), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), QUALCOMM (QCOM) and Schlumberger (SLB).

Enstar Group trades on the NASDAQ under the ticker symbol "ESGR."

Enstar Group's stock is owned by many different institutional and retail investors. Top institutional investors include Envestnet Asset Management Inc. (0.02%). Company insiders that own Enstar Group stock include Bernard F Becker, Dominic Francis Mich Silvester, Guy Thomas Anthony Bowker, Hans-Peter Gerhardt, Orla Gregory, Paul James O'shea and Robert J Campbell. View institutional ownership trends for Enstar Group.

ESGR stock was bought by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc.. Company insiders that have bought Enstar Group stock in the last two years include Bernard F Becker, Dominic Francis Mich Silvester, Guy Thomas Anthony Bowker, Hans-Peter Gerhardt, Orla Gregory, and Paul James O'shea. View insider buying and selling activity for Enstar Group.

Shares of ESGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ESGR stock can currently be purchased for approximately $155.99.

Enstar Group has a market capitalization of $3.45 billion and generates $2.57 billion in revenue each year. Enstar Group employs 1,444 workers across the globe.

The official website for Enstar Group is www.enstargroup.com.

Enstar Group's mailing address is 22 QUEEN STREET, HAMILTON D0, HM JX. The insurance provider can be reached via phone at 441-292-3645 or via email at [email protected]